Fundraising Fox
Deliverbio
1 known investors
Find your way into Deliverbio
Sign up to see every warm intro you have to Deliverbio
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Deliverbio team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Deliver Biosciences develops a nanoparticle-based delivery platform to genetically engineer cells inside patients (in vivo) for cell and gene therapies, using programmable targeting to transport payloads such as DNA and mRNA to specific cell types. Its first product targets T-cells to deliver a CAR gene for cancer immunotherapy, with longer-term applications in autoimmune, neurodegenerative, and cardiovascular diseases.
Investors · 1
SciFounderslisted by SciFoundersSan Francisco · $1M
How we know: the VCSheet dataset · Not right? Tell us
Frequently asked questions
- What does Deliverbio do?
- Deliver Biosciences develops a nanoparticle-based delivery platform to genetically engineer cells inside patients (in vivo) for cell and gene therapies, using programmable targeting to transport payloads such as DNA and mRNA to specific cell types. Its first product targets T-cells to deliver a CAR gene for cancer immunotherapy, with longer-term applications in autoimmune, neurodegenerative, and cardiovascular diseases.
- Who are Deliverbio's investors?
- Deliverbio's investors include SciFounders.